share_log

Piper Sandler Reiterates Overweight on Cue Biopharma, Maintains $8 Price Target

Moomoo 24/7 ·  Apr 3 12:01

Piper Sandler analyst Edward Tenthoff reiterates Cue Biopharma (NASDAQ:CUE) with a Overweight and maintains $8 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment